GW Pharmaceuticals (GWPH -2.8%) slips on below average volume in apparent response to social media comments about an epileptic patient's father who has been unable to procure Epidiolex for about a week and the frequency of his daughter's seizures have increased.
Recommended For You
Comments (53)
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.